Charles River Laboratories | CRL - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Agilent USD 39.08B 6.43B 2026-06
Align Technology USD 12.08B 198M 2026-06
Bio-Rad Laboratories USD 7.87B 390M 2026-06
Bruker USD 9.16B 3.66B 2026-06
Cardinal Health USD 55.64B 5.92B 2026-06
Charles River Laboratories USD 10.39B 2.54B 2026-06
Cigna USD 72.93B 2.59B 2026-06
Concord Medical Services Hldg CNY 117.2M 61.02M 2025-12
CVS Health USD 132B 39.95B 2026-06
Danaher USD 138.86B 10.4B 2026-06
Dentsply International USD 2.13B 191M 2026-06
Elevance Health USD 83.98B 19.68B 2026-06
Humana USD 47.69B 26.88B 2026-06
Illumina USD 26.71B 8.84B 2026-06
Incyte USD 22.65B 3.92B 2026-06
IQVIA Holdings USD 32.25B 3.62B 2026-06
Laboratory Of America USD 22.96B 1.03B 2026-06
Lakefront Biotherapeutics EUR 1.73B 2.64M 2026-06
Lonza CHF 39.68B 980.61M 2025-06
McKesson USD 88.46B 17.53B 2026-06
Merck EUR 18.98B 27.8B 2026-06
Mettler Toledo International USD 25.82B 278M 2026-06
Novartis USD 240.59B 67.17B 2026-06
Pfizer USD 138.44B 15.37B 2026-06
Quest Diagnostics USD 23.46B 1.77B 2026-06
Revvity USD 12.69B 2.75B 2026-06
Thermo Fisher Scientific USD 190.65B 7.99B 2026-06
United Therapeutics USD 23B 2.19B 2026-06
UnitedHealth USD 377.45B 131.84B 2026-06
Veradigm USD 525M 621M 2026-03
Waters USD 37.24B 7.38B 2026-06
West Pharmaceutical Services USD 25.36B 7.3B 2026-06